We recently spoke with a leading cardiologist specializing in echocardiography and hypertrophic cardiomyopathy (HCM), whose clinical work focuses on caring for adults with this complex genetic heart condition and whose research focuses on advancing risk prediction and early diagnosis through advanced imaging and computational analysis.

Ultrasound remains one of the most widely used imaging modalities in medicine. It’s real-time, radiation-free, and comparatively cost-effective. Yet as clinical expectations rise, innovation pressure across the entire ultrasound stack, from software to sensors, has been squeezed as well.  

Interview with Dr. Sonny Bhalla, Medical Director, Kinetix Medicine

Investment to support clinical studies of Sonus Microsystem’s wearable ultrasound patch FOR IMMEDIATE RELEASE: October 23, 2025 VANCOUVER, British Columbia:   Providence Health Care Ventures  (PHCV), a strategic catalyst for health care innovation, announced today a strategic investment in Sonus Microsystems , a leader in innovative ultrasound technology, alongside angel investors including physicians in the cardiac care field. PHCV's investment marks a significant milestone

Healthcare needs imaging that behaves like a vital sign and can deliver continuous, trending, and actionable results. The goal is not just a better image at a single moment. It is better timing, earlier detection, and broader access.

Sonus Microsystems, developers of an AI-powered ultrasound wearable for autonomous on-demand ultrasound, today announced the company has entered a Collaboration Agreement with Kinetix Medicine (“Kinetix”).

You’ve entered an Emergency Room filled with people who, like you, are all seeking medical help. People are scattered around the ER, all...

Recent research, including a prospective clinical study at the PRIME Centre at BC Women’s Hospital, sheds light on the importance of the placenta in fetal development.